"The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP). The device, which includes a small video camera, transmitter "...
QUIXIN® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
Streptococcus (Groups C/F)
Streptococcus (Group G)
Viridans group streptococci*
Acinetobacter lwoffii *
*Efficacy for this organism was studied in fewer than 10 infections
DOSAGE AND ADMINISTRATION
DaysB 1 and 2
Instill one to two drops in the affected eye(s) every 2 hours while awake, up to 8 times per day.
Days 3 through 7
Instill one to two drops in the affected eye(s) every 4 hours while awake, up to 4 times per day.
Dosage Forms And Strengths
5 cc bottle filled with 5 mL sterile ophthalmic solution of levofloxacin, 0.5%.
QUIXIN® (levofloxacin ophthalmic solution) 0.5% is supplied in a white, low density polyethylene bottle with a controlled dropper tip and a tan, high density polyethylene cap.
5mL fill in a 5cc container ---NDC 68669-135-05
Store at 15° – 25°C (59° – 77°F)
Manufactured by: Santen Oy, P.O. Box 33, FIN-33721 Tampere, Finland Licensed from: Daiichi Sankyo Co., Ltd., Tokyo, Japan Revised: Nov 2014This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 12/19/2014
Additional Quixin Information
Quixin - User Reviews
Quixin User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.